Meridith, a fitness trainer and mother of three, was diagnosed with stage 4 melanoma in September 2023. Despite being physically fit and vigilant about her skin health, she experienced no warning signs until a sudden seizure led to her diagnosis.
Interviewed by: Taylor Scheib Edited by: Katrina Villareal
Doctors discovered two brain metastases connected to her stage 4 melanoma, one of which was operable. She underwent a craniotomy that successfully removed one tumor, but the second, inoperable tumor presented ongoing challenges. Seeking alternatives to radiation, Meredith’s network led her to an expert at MD Anderson who proposed immunotherapy, which effectively attacked the tumor. However, the treatment triggered severe side effects, including seizures and encephalitis, leading to a prolonged recovery.
Meridith’s year-long recovery has been marked by physical, mental, and emotional challenges. After seven more seizures in 2024, she focused on lifestyle changes to support brain health. While returning to her previous fitness activities has been slow, she finds healing in nature, spirituality, and spending time with family. Her experiences have brought a new perspective on life, emphasizing gratitude, faith, and the importance of close relationships.
Meridith continues to navigate survivorship with regular scans and a profound sense of purpose, offering encouragement to others facing similar struggles. She believes in the power of hope, community, and finding joy in life’s small moments, even amidst adversity. Her message is one of resilience, emphasizing that light and support can overcome even the darkest times.
Name: Meridith B.
Age at Diagnosis:
43
Diagnosis:
Melanoma
Staging:
Stage 4
Symptom:
Seizure
Treatment:
Surgery: craniotomy (to remove a brain metastasis)
Immunotherapy
This interview has been edited for clarity and length. This is not medical advice. Please consult with your healthcare provider to make informed treatment decisions.
The views and opinions expressed in this interview do not necessarily reflect those of The Patient Story.
Symptoms: Severe pain on the side pain that worsened over time, pelvic pain and a feeling of pressure resembling labor, swollen lymph node on the cheek Treatments: Multiple surgeries to remove tumors, targeted therapy (Opdualag/nivolumab and relatlimab-rmbw) ...
Ashlee was diagnosed with stage 4 Burkitt lymphoma on July 9, 2024. Before her diagnosis, she had been active and health-conscious, even competing as a bodybuilder. In June 2024, she experienced abdominal pain, night sweats, and some bleeding, which she initially attributed to her IUD and the intense physical demands of bodybuilding. However, things took a turn when she noticed a mass on her abdomen during a workout. She went to an ER where a CT scan revealed a large mass near her femoral artery, though doctors were uncertain of its nature.
Ashlee sought further medical evaluation at the University of Florida, where the mass was discovered to be much larger than expected and appeared to be cancerous. After a biopsy, she received the devastating news that she had stage 4 Burkitt non-Hodgkin lymphoma. The doctors warned her of a 70% chance of not surviving, given the aggressive nature of the lymphoma and its potential spread to her central nervous system.
Her treatment began promptly with chemotherapy, starting with a spinal tap to check for cancer in her brain and spine. Her chemotherapy regimen included five-day continuous drips every three weeks. The side effects were intense, including an allergic reaction to one of the drugs that caused her to stop breathing. Despite the challenges, Ashlee continued to work full-time while undergoing treatment, maintaining a sense of normalcy for her two young children, especially her daughter who struggled with the illness.
Throughout six chemotherapy treatments, Ashlee dealt with extreme physical exhaustion, nausea, and other side effects. She remained focused on being present for her children, despite the toll the illness took on her body. By the end of her treatment, she was physically drained, but mentally, she found herself reflecting on the fragility of life, mending relationships, and prioritizing time with her family. She also began to come to terms with the emotional challenges of living with cancer, including the impact it had on her future and personal life.
Currently, Ashlee is on a sabbatical, enjoying time with her children and focusing on her health. She is dealing with medical menopause as a result of her treatment and remains concerned about the possibility of relapse, though her doctors remain optimistic. Moving forward, she will continue to have regular check-ups, including bloodwork and CT scans every three months.
Name: Ashlee K.
Age at Diagnosis:
29
Diagnosis:
Burkitt lymphoma
Staging:
Stage 4
Symptoms:
Abdominal pain
Night sweats
Visible mass in the abdomen
Treatments:
Surgery: partial colectomy (removed 14 inches of the intestine)
Chemotherapy
This interview has been edited for clarity and length. This is not medical advice. Please consult with your healthcare provider to make informed treatment decisions.
The views and opinions expressed in this interview do not necessarily reflect those of The Patient Story.
Stephanie’s Stage 2B ALK+ Non-Small Cell Lung Cancer Story
Stephanie’s stage 2 lung cancer story began with a mild, intermittent cough in the spring of 2021, which she dismissed as allergies or weather-related. When her cough persisted, she mentioned it during a routine check-up with her general practitioner. After a chest X-ray, a mass was discovered on her lung. This led to a CT scan, which revealed a spiculated mass (having spikes or points on the tumor surface), raising concerns about cancer.
The diagnosis came after a bronchoscopy, which confirmed the mass was cancerous, specifically adenocarcinoma, a type of non-small cell lung cancer. She underwent a lobectomy, during which her surgeon removed two lobes of her lung to ensure all cancerous tissue was eliminated. Stephanie was subsequently diagnosed with stage 2B lung cancer. The pathology report confirmed that her lymph nodes were cancer-free and that she had clean margins with no signs of vascular or pleural invasion.
Following her surgery, Stephanie learned she was ALK-positive, a genetic mutation associated with non-smokers and younger lung cancer patients. Due to this, her treatment plan included chemotherapy and targeted therapy. After completing four rounds of chemotherapy, Stephanie was advised to begin targeted therapy, which is typically used in stage 4 cases but has shown potential benefits for earlier-stage patients, like her stage 2 lung cancer. Stephanie decided to follow this advice and has been on targeted therapy since completing chemotherapy.
Stephanie’s motivation throughout her diagnosis and treatment has been her young daughter. She remains dedicated to doing everything to stay healthy for her family. While she has had clean scans and blood work for the past three years, she continues to take her medication daily, hoping it prevents the cancer from returning. She advises others to know their biomarkers, seek second opinions, and join support groups for personalized guidance and support.
Name: Stephanie W.
Age at Diagnosis:
37
Diagnosis:
Non-Small Cell Lung Cancer
Staging:
Stage 2B
Mutation:
ALK
Symptoms:
Persistent cough
Wheezing
Treatments:
Surgery: bilobectomy
Chemotherapy
Targeted therapy
This interview has been edited for clarity and length. This is not medical advice. Please consult with your healthcare provider to make informed treatment decisions.
The views and opinions expressed in this interview do not necessarily reflect those of The Patient Story.
Jennifer was diagnosed with early onset colon cancer in 2017 (stage 3) at the age of 23, which progressed to stage 4 in 2020. Her diagnosis came after an iron deficiency flagged by her endocrinologist led to further testing and a colonoscopy revealing a 5 cm tumor. Before her diagnosis, she experienced scattered symptoms including weight loss, coughing, vomiting, sciatica pain, and persistent fatigue, which were initially attributed to depression, stress, and other conditions.
Interviewed by: Taylor Scheib Edited by: Katrina Villareal
Treatment began with a colectomy in December 2017, followed by six months of FOLFOX chemotherapy. Despite an initial remission, Jennifer’s cancer returned in her lungs in 2020, discovered during post-stroke scans after a medical complication left her blind in one eye. Subsequent treatments included FOLFIRI chemotherapy, cetuximab immunotherapy, and two lung wedge resections to remove nodules.
Jennifer candidly discusses the challenges of navigating complex medical care that came with her early onset colon cancer diagnosis, including periods of insufficient oncology support, medical advocacy struggles, and emotional tolls. She credits her recovery to persistence, family support, and pushing for surgeries against her oncologist’s preference for extended chemotherapy. A wake-up call from her health crises led her to improve her lifestyle, take control of her medical care, and stay deeply involved in her treatment plans.
Reflecting on her experiences, Jennifer emphasizes the importance of advocating for oneself, accepting past circumstances, and maintaining a focus on the present. Her message to others is clear: trust your medical team but actively participate in decisions, avoid panic over statistics, and focus on actionable steps toward treatment and recovery.
Name: Jennifer T.
Age at Diagnosis:
23
Diagnosis:
Colon Cancer
Staging:
Stage 3 (2017)
Stage 4 (2020)
Symptoms:
Weight loss
Coughing
Vomiting
Sciatica pain
Fatigue
Treatments:
Surgeries: colectomy, lung wedge resection on both lungs
Chemotherapy: FOLFOX, FOLFIRI
Immunotherapy: cetuximab
This interview has been edited for clarity and length. This is not medical advice. Please consult with your healthcare provider to make informed treatment decisions.
The views and opinions expressed in this interview do not necessarily reflect those of The Patient Story.
Nicole, a nurse and single mother of three from Florida, was diagnosed with chronic lymphocytic leukemia (CLL) a week before her 39th birthday. She initially attributed her symptoms—extreme fatigue, night sweats, and persistent lumps on her neck—to the demands of her job during the pandemic or possibly pre-menopause. After a series of misdiagnoses, including post-COVID fatigue and infections, Nicole’s OB/GYN referred her to an ENT, triggering a series of tests that led to her leukemia diagnosis.
Interviewed by: Taylor Scheib Edited by: Katrina Villareal
Despite the emotional and logistical challenges, Nicole adopted a pragmatic approach, focusing on understanding her disease and navigating her treatment plan. Nicole underwent an initial six-month treatment with a BCL-2 inhibitor and monoclonal antibody. While the therapy brought her into remission temporarily, symptoms such as night sweats and fatigue resurfaced, prompting renewed treatment of the BCL-2 inhibitor.
Financial struggles and logistical hurdles with insurance and medication access compounded the difficulties of her chronic lymphocytic leukemia diagnosis. However, Nicole relied on support from family, friends, and her children, alongside advocacy and connection with others facing similar challenges, to maintain her resolve.
Throughout her experience, Nicole emphasized the importance of self-advocacy, understanding her diagnosis, and not comparing her circumstances to others. Her coping mechanisms included leveraging social media to share her experiences, seeking guidance from a CLL specialist, and shifting her perspective on life to prioritize meaningful moments with her children. Nicole’s ultimate hope is for greater awareness and resources for CLL and blood cancers, and encourages others facing similar situations to advocate for themselves, seek help, and live in the moment.
Name: Nicole B.
Age at Diagnosis:
38
Diagnosis:
Chronic Lymphocytic Leukemia
Symptoms:
Extreme fatigue
Night sweats
Lumps on neck
Rash
Shortness of breath
Treatments:
BCL-2 inhibitor
Monoclonal antibody
This interview has been edited for clarity and length. This is not medical advice. Please consult with your healthcare provider to make informed treatment decisions.
The views and opinions expressed in this interview do not necessarily reflect those of The Patient Story.
Marisa shares her experience living with stage 4 synovial sarcoma. Diagnosed initially with stage 3 in 2017, Marisa’s symptoms began in high school when she noticed a small bump on her foot. Despite consultations with podiatrists over the years, the bump was misdiagnosed as a benign cyst until after its removal in 2017. By that time, the lump had grown significantly during her pregnancy. The devastating cancer diagnosis came when her daughter was six weeks old, marking a life-changing moment.
Marisa’s treatment included chemotherapy, a below-knee amputation in 2017, and multiple surgeries for lung metastases, starting in 2020. She underwent four pulmonary wedge resections, a segmentectomy, and later, radiation therapy to target residual cancer. Unfortunately, the cancer became more aggressive, spreading to her bones and lungs by early 2023. Despite numerous treatments, including 27 lung radiation sessions and systemic chemotherapy, Marisa remains optimistic and continues to monitor her health closely.
Mentally and emotionally, the impact of cancer has been profound. Marisa finds it challenging to balance parenting, work, and being a stage 4 cancer patient. She’s candid about the toll it takes on her and her family, especially explaining her illness to her young daughter. However, Marisa has chosen to focus on small joys—mundane daily tasks and moments with loved ones that now hold deeper meaning.
Marisa emphasizes the importance of self-advocacy in health care, urging others to trust their instincts and pursue answers when something feels wrong. She shares her story to provide hope to others battling sarcoma or cancer. She aims to raise awareness about the disease and inspire others with her determination to live fully, even while managing ongoing health challenges. Her message is clear: life with stage 4 cancer is not the end—it’s an opportunity to cherish each moment and look forward to advancements in medical science.
Name: Marisa C.
Age at Diagnosis:
24
Diagnosis:
Synovial Sarcoma
Staging:
stage 3 (2017)
Stage 4 (2021)
Symptom:
A small bump on the foot (stable for years, then grew during pregnancy), pain when pressed, difficulty wearing closed shoes
Treatments:
Surgeries: below-knee amputation, pulmonary wedge resections, and segmentectomy
Chemotherapy
Radiation: lungs and hip
This interview has been edited for clarity and length. This is not medical advice. Please consult with your healthcare provider to make informed treatment decisions.
The views and opinions expressed in this interview do not necessarily reflect those of The Patient Story.
Symptoms: Pain behind left knee, needle-like sensation in left foot Treatments: Surgery to remove what was thought to be benign tumor, chemotherapy, final surgery, radiation (36 sessions) ...
Bella, an Australian living in the UK, shares her experience with malignant paraganglioma, diagnosed after years of medical gaslighting and misdiagnoses. Her symptoms began when she was 15 with severe vomiting, chronic cough, dizziness, a neck lump, and extreme weight loss. Misdiagnosed with anorexia and bulimia, she endured invasive and ineffective treatments for years. Her condition deteriorated until a general physician recognized the seriousness of her symptoms, leading to an ultrasound and eventual diagnosis of a paraganglioma.
Surgery to remove a large neck tumor was extensive, lasting eight hours, and left Bella with stroke-like symptoms, paralysis on one side of her face, and difficulties swallowing and speaking. Subsequent testing revealed the tumor was malignant and had spread. Bella underwent six weeks of intensive radiotherapy, during which she suffered severe pain, hearing loss, and isolation.
Her treatment revealed a genetic mutation in her family that predisposes them to certain cancers. Although she has faced recurring health scares and complications over the years, Bella has worked to rebuild her life. Struggling with identity and mental health post-treatment, she initially turned to partying as a coping mechanism. The COVID-19 lockdown, however, marked a turning point, leading her to seek deeper healing through community support. Bella found solace and strength in a women’s cancer survivor group, which helped her realize the importance of connection in healing.
Now, Bella emphasizes the power of community and advocates for understanding that the challenges of cancer extend far beyond treatment. She encourages others to find support networks and validates the emotional toll of living with and recovering from cancer.
Name: Bella J.
Age at Diagnosis:
19-20
Diagnosis:
Malignant Paraganglioma
Symptoms:
Severe vomiting
Chronic cough
Dizziness
Swelling in the neck
Low heart rate
Extreme weight loss
Hair loss
Dental issues
Vocal strain
Persistent pain and exhaustion
Treatments:
Surgeries: approximately 15 procedures, including an eight-hour tumor removal
Radiotherapy
Physical therapy: for arm mobility and swallowing techniques
TW // Suicidal ideation
This interview has been edited for clarity and length. This is not medical advice. Please consult with your healthcare provider to make informed treatment decisions.
The views and opinions expressed in this interview do not necessarily reflect those of The Patient Story.
Symptom: None; found the cancers during CAT scans for internal bleeding due to ulcers Treatments: Chemotherapy (capecitabine + temozolomide), surgery (distal pancreatectomy, to be scheduled) ...
Kristin was diagnosed with stage 3A melanoma in April 2008 at the age of 38. Her diagnosis came unexpectedly during her attempts to conceive. While recovering from a fertility procedure, she noticed a change in a lifelong mole on her leg. Prompted by her family history of basal cell carcinoma and her dermatologist’s biopsy, she was diagnosed within days.
Kristin underwent extensive treatments, including two surgeries to remove the melanoma and affected lymph nodes, followed by a challenging year of interferon therapy, which left her with flu-like symptoms and required regular interruptions due to blood count drops. Despite the physical and emotional toll, she worked throughout her treatment and planned a celebratory trip to Alaska once her therapy concluded.
The stage 3A melanoma diagnosis had profound effects on Kristin’s personal life. Her inability to continue trying for children led to a period of depression, but she eventually found emotional resilience through activities like skydiving and advocacy. She began raising awareness about melanoma prevention and promoting the importance of early detection.
Kristin also navigated the complexities of being a caregiver when her mother battled cancer. This experience deepened her understanding of the patient-caregiver dynamic and strengthened her resolve to advocate for improved support and research in oncology.
Sixteen years after her stage 3A melanoma diagnosis, Kristin continues to educate and inspire others, emphasizing melanoma’s preventability and the importance of self-advocacy in healthcare. Her story underscores the critical role of research, the availability of modern treatments, and the emotional challenges survivors face while redefining their purpose.
Name: Kristin M.
Age at Diagnosis:
38
Diagnosis:
Melanoma
Staging:
Stage 3A
Symptom:
Change in color and border of a mole on her leg
Treatments:
Surgeries: melanoma and lymph node removal
Immunomodulator: interferon
This interview has been edited for clarity and length. This is not medical advice. Please consult with your healthcare provider to make informed treatment decisions.
The views and opinions expressed in this interview do not necessarily reflect those of The Patient Story.
Symptoms: Severe pain on the side pain that worsened over time, pelvic pain and a feeling of pressure resembling labor, swollen lymph node on the cheek Treatments: Multiple surgeries to remove tumors, targeted therapy (Opdualag/nivolumab and relatlimab-rmbw) ...
Building Bonds Episode 2: How to Find and Partner with a Doctor for Better Waldenström Care
Finding a doctor is important in your Waldenström macroglobulinemia care. A strong partnership leads to more informed decisions, personalized care, and a greater sense of control. Patient advocate Pete DeNardis, hematologist-oncologist Dr. Jonas Paludo from Mayo Clinic, and patient advocate Lisa Ramirez discuss how her decisions led to being treated by Dr. Paludo and forming a trusted patient-doctor relationship.
Building Bonds Ep. 2: How to Find and Partner with a Doctor for Better Waldenström Care
Hosted by The Patient Story
Finding a match is important in your Waldenström care. A strong partnership leads to more informed decisions, personalized care, and a greater sense of control. Join host and patient advocate Pete DeNardis, Dr. Jonas Paludo from Mayo Clinic, and patient advocate Lisa Ramirez as she discusses how her decisions led to being treated by Dr. Paludo and forming a trusted patient-doctor relationship.
Discover the importance of second opinions and how even top specialists recommend them. Understand how a Waldenström macroglobulinemia specialist can provide a unique perspective having seen more cases. Learn about shared decision-making in Waldenström treatment. Hear first-hand experiences of navigating a chronic cancer with your doctor by your side. Get practical tips for advocating for yourself or a loved one in the treatment process.
This interview has been edited for clarity and length. This is not medical advice. Please consult with your healthcare provider for treatment decisions.
Thank you to Pharmacyclics, an AbbVie Company, for its support of our patient education program. The Patient Story retains full editorial control over all content.
Tiffany Drummond: I’m a patient advocate with over 20 years of experience in cancer research. My journey as a care partner began when my mother was diagnosed with endometrial cancer in 2014. I quickly realized the challenges of finding reliable information to support her care, so I am committed to helping others avoid similar difficulties.
At The Patient Story, we create programs to help you figure out what’s next. Think of us as your go-to guide for navigating the cancer journey. From diagnosis to treatment, we’ve got you covered with real-life patient stories and educational programs with subject matter experts. I’m your personal cheerleader, here to help you and your loved ones best communicate with your healthcare team as you go from diagnosis through treatment and survivorship.
We want to give a big thank you to The Leukemia & Lymphoma Society for its partnership. The LLS offers incredible free resources, like their Information Specialists who help you communicate with members of your healthcare team and provide information about treatment options.
We want to thank our sponsor, Pharmacyclics, an AbbVie company, for its support, which helps us host more of these programs for free to our audience. The Patient Story retains full editorial control over all content. While we hope you find this helpful, please keep in mind that the information provided in this program is not a substitute for medical advice. Pete, a patient advocate and Waldenström’s survivor, will lead the conversation.
Peter DeNardis, IWMF Chair Emeritus
Peter DeNardis: I’m currently the chair emeritus of the International Waldenström’s Macroglobulinemia Foundation. I have been a long-time volunteer for the organization and a patient myself. I was diagnosed 20 years ago and I’m well aware of the importance of a strong patient-doctor relationship. I look forward to learning from our esteemed panelists about how best to build and maintain that relationship.
With us is Dr. Jonas Paludo, a hematologist-oncologist and assistant professor of medicine and oncology at Mayo Clinic in Rochester, Minnesota. His research interests include studies to understand the biology, genetics, and therapy of lymphoma and plasma cell disorders, and he is also a noted researcher in Waldenström’s.
Lisa Ramirez, Patient Advocate
Lisa Ramirez: I was diagnosed in 2021. I was getting into a doctoral program and had to do some routine testing and physical exams, and in the process, I was diagnosed with Waldenström’s macroglobulinemia. The diagnosing oncologist was retiring, so he passed me on to another doctor in his practice.
I did a lot of research on Waldenström’s immediately and read Dr. Gertz’s recommendation on getting a second opinion, which I appreciated. I looked for the doctor who I thought would be best in getting a second opinion from and that was Dr. Paludo since he specialized in Waldenström’s in young people. I got another opinion from a physician at a major cancer center in the state in which I live as well.
I had a great rapport with Dr. Paludo immediately, but I initially thought I would only see him for a second opinion since I lived in Texas and he was at Mayo Clinic. I made it work and secured Dr. Paludo as my primary oncologist. I was very pleased about that.
Proactively Participating in Your Care
Peter: It’s good that you immediately did research and also went for a second opinion. Is it appropriate to say that you were an involved patient from the start?
Lisa: Yes. I work in public health. I’m a natural researcher and a very curious person. I wanted to learn as much as I possibly could and as quickly as I could about Waldenström’s to plan out my course of treatment and to be a well-informed patient.
I listened to all the lectures I could get my hands on and tried to understand the philosophies of the different cancer institutes. They seem to have differing philosophies about treatment and I tried to find one that fit with my personal philosophy and how I wanted to approach treatment.
I wanted to learn as much as I possibly could and as quickly as I could about Waldenström’s to plan out my course of treatment and to be a well-informed patient.
Lisa Ramirez
Signs and Symptoms
Peter: Looking back, do you think you had any symptoms that you weren’t paying attention to at the time?
Lisa: I was having night sweats, but I didn’t I thought I was experiencing early pre-menopause symptoms. Now I know the difference between hot flashes and night sweats. There’s a big difference.
I had some testing done because of other reasons and there was a note to rule out lymphoma and to check in six months after. Right at the six-month mark, my primary physician had me see a hematologist because of those test results. I had zero symptoms then. I felt great.
Looking back, I had some input from other oncologists that perhaps I had the disease for so long that I thought I felt good. That small incremental change in a negative way can go unnoticed, but I thought, “Does it matter? If I believe I feel good, then I feel good.”
Insurance Concerns
Lisa: The average time between diagnosis and treatment is about two and a half years and that’s about how long it took for me, so I was right on pace with the average.
Peter: You got a second opinion in a different state. You live in Texas while Mayo Clinic is in Minnesota. Did you have any financial or insurance issues trying to see Dr. Paludo?
Lisa: Surprisingly not. I received some treatment in another city in Texas. When you break down the costs, that treatment was more expensive.
Different institutions have different priorities in terms of testing and the amount of testing at checkups. In my case, the cost of the additional testing outweighed the cost of travel to Minnesota. It ended up being more cost-effective and worth it to travel to receive treatment at Mayo Clinic.
Peter: You’re very fortunate in that regard. I’m glad that worked out for you. You’re under great care and it appears that right from the start, you’re a very involved, proactive patient, so I applaud you for that and hope that other patients can take your lead.
WM at a Glance
Peter: Dr. Paludo, many of us patients have a general idea of what Waldenström’s macroglobulinemia is, but can you give a 30,000-foot view explanation of what the disease is?
Dr. Jonas Paludo: Waldenström’s is a rare type of blood cancer. It’s a form of an indolent or slow-growing subtype of a B-cell non-Hodgkin’s lymphoma. It’s a disease that has some overlapping features between lymphoma and myeloma, but it’s a type of blood cancer.
Common WM Questions
Peter: You see patients either coming initially to see you or for a second opinion. They probably have similar questions, but in your experience, what are the more common questions that patients ask?
Dr. Paludo: I can group the most common questions into three specific categories. In one shape or another, they’re trying to understand: What is Waldenström’s? What is this disease? Then the next one is: what do we do about this? Do we have to do anything about it right now? What it will look like? And then the third one is: what is my prognosis? What can I expect out of this disease?
Peter: Those questions are pretty common for Lisa and me when we were first diagnosed, so it’s good to see those questions are still being asked.
Diagnostic parameters, treatment options, follow-up testing, and surveillance are not as well-established in rare diseases as they are in more common diseases.
Dr. Jonas Paludo
Getting a Second Opinion
Peter: Many in the medical community and even the IWMF itself encourage patients to get a second opinion in certain circumstances. Dr. Paludo, as a healthcare provider, what are your thoughts on patients getting second opinions?
Dr. Paludo: Waldenström’s is a rare disease and like any rare disease, a second opinion should always be considered. Diagnostic parameters, treatment options, follow-up testing, and surveillance are not as well-established in rare diseases as they are in more common diseases or more common forms of cancer, like breast cancer or colon cancer, for example. That’s where a second opinion can help.
In addition, the familiarity of physicians with the disease or the current evidence and data of the disease can be quite variable. It’s part of reality. We can’t keep up with all the information generated daily for all diseases. Getting a second opinion from someone who has more experience or more interest in that specific type of rare disease is very important and adds a lot to the treatment and management.
I always encourage second opinions. To be honest, with most patients I see with Waldenström’s, I’m the one giving the second opinion. But for the patients who we see that are local, I encourage asking for another opinion elsewhere to have different points of view. I don’t think a second opinion would ever hurt a patient. It can only add information and help with the treatment and plan.
Peter: That’s a good point and hopefully they’re not trying to juggle three different opinions. In Lisa’s case, it was the one that she felt more comfortable with, which is appropriate.
Dr. Paludo: That’s a potential downside, but the benefits of a second opinion outweigh that downside.
Lisa: Waldenström’s is so different in terms of it being a cancer because you want to time treatment perfectly and take into account your quality of life. With a lot of other cancers, there’s a rush to treat and there are very specific treatment regimens. With Waldenström’s, you’re playing a very long game of chess.
You want your partner to be someone who you trust and who understands your quality of life and your age as you’re moving along the course of treatment. You’re going to want someone who understands you well enough, to keep pace, and who has a similar philosophy and approach to treatment. With Waldenström’s in particular compared to other cancers or other diseases, it’s important when selecting an oncologist that there’s a good fit.
Different cancer centers can appeal to different types of people. Mayo Clinic and Dr. Paludo were the perfect fit for me.
Dr. Jonas Paludo
Knowing Your Options
Peter: How did you know where to go for a second opinion? You mentioned Dr. Gertz’s presentation, but how did you figure out what your options were?
Lisa: The resources from the IWMF immediately pointing to Dr. Gertz and understanding Mayo Clinic’s philosophy led me there and looking into physicians there. I found Dr. Paludo in relation to Waldenström’s and other aspects of Waldenström’s that were of particular interest to me. I immediately sought him out for a second opinion.
I seem to resonate more with the philosophy of Mayo Clinic. They seem to have an approach that is slower to overreact. Their approach feels more strength-based rather than fear-based and I respond to that. When I need to embark on an intimidating treatment like chemotherapy, I want my partner to be able to reassure me that I’m strong enough, that I’ve prepared enough, and that it is the right time.
I understand that people have different motivations for starting treatment and some people can be more motivated by fear-based approaches. I don’t respond well to that. I respond better to a strength-based approach and the reassurance that all my questions are answered and that there’s enough time spent understanding the procedure or what’s happening with the progress of the disease. I find direct information very reassuring.
I have had oncologists who took a different approach where they feel nervous about my condition and then I start to feel very nervous and anxious. I know that it’s best to time treatments correctly and wait a little bit longer. It’s a fine line. Different cancer centers can appeal to different types of people. Mayo Clinic and Dr. Paludo were the perfect fit for me.
Finding a WM Specialist
Peter: Dr. Paludo, you mentioned that some patients come to you initially while others come for second opinions. If you’re telling a patient to get a second opinion, where do you direct them to? And for the patients who come to you initially, how did they find out about you in the first place?
Dr. Paludo: I also rely a lot on the IWMF resources to help patients decide on where to go next. There are so many factors, like insurance coverage and cost of travel, that are so particular to each patient, so I try not to be very specific. I point them to resources that they can look at to see which one makes more sense based on insurance, cost, travel, timing, family members, where they are, and things like that.
As with most rare diseases, you find more experience in bigger centers because they tend to see more patients with their rare diseases. It doesn’t necessarily mean that’s the only place you can find experience and expertise. It’s just the more common place where you can find expertise for rare diseases. The IWMF helps with pinpointing areas with more expertise or experience with Waldenström’s than other sites.
Peter: Because of my involvement with the IWMF, I’m well aware of the services they provide. On their website, they have a list of top doctors to go to for a second opinion regardless of what part of the world you’re in. The IWMF also has online discussion groups and Facebook groups where you can ask other patients who they go to. Granted, that’s word of mouth from one patient to another, but you can form an idea of who are the more noted doctors and who you could see if you want a second opinion.
The biggest challenge that I see is often related to indications to start treatment… sometimes it’s better if we don’t jump into treatment and instead sit tight and watch very closely.
Dr. Jonas Paludo
Building Bonds Ep. 2: How to Find and Partner with a Doctor for Better Waldenström Care
Hosted by The Patient Story
Finding a match is important in your Waldenström care. A strong partnership leads to more informed decisions, personalized care, and a greater sense of control. Join host and patient advocate Pete DeNardis, Dr. Jonas Paludo from Mayo Clinic, and patient advocate Lisa Ramirez as she discusses how her decisions led to being treated by Dr. Paludo and forming a trusted patient-doctor relationship.
Peter: Dr. Paludo, what do you see that some healthcare professionals don’t get right about a WM patient?
Dr. Paludo: Waldenström is such a unique disease that the biggest challenge that I see is often related to indications to start treatment. Because of the uniqueness of this disease with overlapping features with other indolent lymphomas, sometimes I see more of a generalization of what we do for similar diseases applied to Waldenström’s. I understand where they’re coming from, but it doesn’t always fit with our best practices for Waldenström’s.
They haven’t seen a lot of cases and sometimes it can be difficult for a provider to sit tight on a patient who has a very high IgM level and hold off on doing something. It’s often easier to do something, but sometimes it’s better if we don’t jump into treatment and instead sit tight and watch very closely when patients are asymptomatic or not having significant symptoms.
Peter: I hesitate to say this, but back when I was first diagnosed, there was something called the 10,000 IgM Club. There were a handful of patients who felt that they were okay and feel fine. Their IgM level is 10,000, but their symptoms are fine. In hindsight, that may have not been, but every patient is different. You’re exactly right. It depends on a patient’s symptoms and how they’re feeling along with the blood values. It’s critical to go to a specialist if you can.
I’m Newly Diagnosed. What Now?
Peter: Let’s turn to the important role of the doctor-patient relationship in managing your disease course, both short- and long-term, especially about WM. It’s considered incurable, but with the more novel agents that have come around in the last 5 or 10 years, it’s much more treatable.
Lisa, you mentioned your path to getting a second opinion. What advice would you give to a newly-diagnosed patient who’s looking for care and what do you think is most important?
Lisa: What we’re talking about here is building rapport. You have to be able to trust your oncologist 100%. There are some scary moments and you question yourself. You want to have the reassurance of an oncologist who has expertise in this area, understands you, and has a sense of how uniquely your disease is manifesting.
Every WM patient is a little bit different, so find a physician who you can trust and sees you. Sometimes that’s not something tangible. It’s what occurs during a conversation and a sense that you feel shared insights or philosophies. During my visits with Dr. Paludo, he would ask, “And what else?” I loved that he always left room for all of my questions and he was always very direct with me.
You want to have the reassurance of an oncologist who has expertise in this area, understands you, and has a sense of how uniquely your disease is manifesting.
Lisa Ramirez
Do your research. Understand what it is that you want in terms of your quality of life and what’s important to you.For example, I was going to start treatment under the care of a different oncologist, which would have put at risk my ability to dance ballet on my toes because there was a higher risk of peripheral neuropathy with that particular treatment. At my age, I thought the first treatment I should do perhaps shouldn’t be that one. I was able to have that conversation with Dr. Paludo and talk about things that are important to me.
Oncologists see a lot of different patients and their priority is to save your life and get you treated, which is understandable, but it’s a little bit different with WM. My quality of life includes being able to dance on my toes, so losing feeling in my toes was a big deal. It would have negatively impacted my quality of life had I started with that particular treatment if I had the unfortunate side effect of being unable to feel my toes.
Find an oncologist who understands who you are as an individual, what your quality of life is based upon, what’s important to you, who you feel comfortable sticking with throughout your life, and who will map out a course of treatment that’s going to work for you. One time, Dr. Paludo said, “You’re probably going to have to do all the treatments. We just have to figure out what works for you when.” Everyone’s different, so that’s important.
Deciding to Stay Local or Travel for Your Care
Peter: You have a good rapport with Dr. Paludo. Do you still see a local oncologist in Texas?
Lisa: No, I see Dr. Paludo exclusively. I was already scheduled for treatment somewhere else, but I got cold feet at the last second. The first step in treatment is so critical. It impacts the next move and the next move and the next move. Even though those moves are spaced out—hopefully many years apart—it still sends off a ripple effect.
You want to feel very comfortable with your provider and the institution you’re receiving care from is critical. I had to advocate for myself and say, “I know it doesn’t make sense to seek treatment in a different state and to get my primary care from an oncologist so far away, but we’re going to Minnesota.”
How Often Do You See WM Patients?
Peter: Dr. Paludo, Mayo Clinic is a world-renowned medical institution, but, hopefully, many people with Waldenström’s also understand that it’s world-renowned for Waldenström’s macroglobulinemia. Out of curiosity, can you say how many patients you maybe see a day or in a week that have Waldenström’s?
Dr. Paludo: It’s variable these days, but I estimate about two to three patients a week with Waldenström’s and sometimes as many as five patients a day. We looked at this a few years back and to give some context, if you were to consider all practicing doctors in the US and all newly-diagnosed Waldenström’s patients in a year, each doctor will see a new case of Waldenström’s once every eight years. This gives you a sense of how rare diseases are very, very difficult to come across.
I want the patient to feel empowered that they can ask any question, no matter what it is, and bring up any concerns or fears that are important to them.
Dr. Jonas Paludo
Approaches to Personalized Care
Peter: You and Lisa have a very good doctor-patient relationship. In your experience, does each patient approach you differently? Do you have a different approach depending on what kind of interaction you have or what works best for that patient?
Dr. Paludo: My approach is different for each patient. The things that we always try to discuss and focus on are the main concerns that each patient brings to the visit, which can be different. If someone was recently diagnosed with Waldenström’s versus someone who’s reviewing, studying, researching, and now we’re talking about treatment, there would be some differences in how I approach each patient.
Managing Your Life with WM
Peter: Given that Waldenström’s is becoming more of a manageable disease, what is your guidance to patients when they first come to you as far as dealing with having a disease like ours? You have periods of requiring active treatment and periods of watching and waiting for the next shoe to drop, in a sense.
Dr. Paludo: It depends on the situation, but I’m always trying to discuss the key concepts related to Waldenström’s. We talk about follow-ups and treatment indications. I like to address that because they’re important for the patient, especially if they’re not coming to Mayo for their care.
At the end of the day, we always try to establish trust and an open space. I want the patient to feel empowered that they can ask any question, no matter what it is, and bring up any concerns or fears that are important to them. It’s difficult to do everything in one visit, although we do try, but sometimes we need several visits to discuss all of these.
Peter: That’s very commendable. That should be the model for all clinicians. Unfortunately, a lot of them are pressed for time or dealing with a large patient load, so they don’t make the extra effort, and you should be applauded for doing that.
WM Treatment Options
Peter: Lisa, you had some choices to make concerning treatment. Were you aware of the treatment options before you spoke to Dr. Paludo?
Lisa: Yes. The second oncologist I saw was supposed to be my first treatment opinion. When I started talking to her about the treatments, she said, “Gosh, you sure do know a lot about this. What do you think?” I didn’t get the first opinion that I was hoping for because I had done so much research that the oncologist felt that maybe I had a better sense of what treatment I should start with, which ultimately led me to a second opinion with Dr. Paludo.
I have done a lot of research, which I enjoy doing. It’s not a situation you want to be in, but I work in public health and public health strategy, so I enjoy strategy and research. I wanted to find out as much as I could about the treatment options. From the scientific papers, it’s not always clear. Actual patient experiences are something that’s missed in very scientific journal articles, which can only be shared through patient-to-patient experiences.
With Waldenström’s, that can be additionally challenging because we are each so unique. It’s a full-body disease that manifests differently. The symptoms are different from person to person. There are also fewer females with the disease and fewer people my age, so it can become more difficult to know exactly what to expect even though you do a lot of research.
What reduced my anxiety was talking to Dr. Paludo about being vulnerable about parts of the treatment that I thought were most concerning.
Lisa Ramirez
The Emotional Impact of a WM Diagnosis
Peter: You did a lot of research, but how were you dealing with it emotionally? How did it affect you when you were first diagnosed and how did you deal with the enormity of it?
Lisa: When I was first diagnosed, I was shocked. I knew I couldn’t have the conversation with my daughter that day, so she had a sleepover that night.
After that, I felt somewhat calm about it, even though I do have a history of anxiety disorder. I knew going into treatment that my outcomes would be better if my anxiety was reduced. Stress plays a huge role in your physical health in general, but especially as you undergo something as stressful as chemotherapy where you have a lot on the line.
I made sure to take care of my mental health through exercise and seeing a therapist weekly. What reduced my anxiety was talking to Dr. Paludo about being vulnerable about parts of the treatment that I thought were most concerning. I was able to talk in-depth about how I was concerned about a recurrence of my anxiety and eating disorders in the course of treatment.
Dr. Paludo was able to reassure me that, at any point in time, if I was having concerning symptoms, we could talk about it, but most of all, we could always stop treatment and take a different course of action. That option was never presented to me before by any of the oncologists I had seen. Having that way out and knowing that I had that autonomy was so reassuring and helped me get through a lot of rough times throughout treatment.
I had a pretty good treatment experience. It wasn’t always easy, but it was a lot easier knowing that I had the support of my oncologist to pivot, redirect, and find a different course of treatment that worked better for me. My quality of life was most important to both of us.
Peter: Thatfocus on quality of life is critical. Every patient’s different, both physically and mentally, and it’s important to treat both aspects of how a patient approaches their disease.
Important Takeaways from Initial Consultation
Peter: Dr. Paludo, when you see a patient, what do you want patients and care partners to take away from that initial visit with you? What do you want them to understand?
Dr. Paludo: One of my priorities is to have patients understand that treatment for Waldenström’s is not a sprint but a marathon. It’s a long-term process that involves long-term planning, and we have to consider all short- and long-term strategies for treatment.
I usually say that when you’re getting treatment, you’re not in a long-term commitment. You can always stop and find a different option. I also like to discuss, usually in broad terms, that what we have today for treatment options has an overall similar efficacy. They are different in potential side effects, logistics, duration, and frequency. That often allows patients to focus on the implications of the treatment on their quality of life and their goals.
Once we remove the efficacy piece from the discussion, we can talk more about side effects and logistics. We can focus on how the treatment can help patients achieve what they want at the end of the day, which is improved quality of life, and accomplish what’s important to them. Those are things that I always like patients to take away from those initial discussions about treatment options before even we decide on which treatment to go next.
Lifestyle Changes in the Face of a WM Diagnosis
Peter: Lisa, you wanted to make sure you had a good quality of life. After you were diagnosed and started treatment, did you do anything different? Did you make lifestyle changes to help you emotionally and physically?
Lisa: Absolutely. Dr. Gertz said that frailty is the enemy, so I immediately got a personal trainer and hit the gym. People train for marathons. This is the rest of my life. I don’t want chemotherapy to knock me down. I need to be as fit as possible.
I also participated in an educational session on nutrition through The Leukemia & Lymphoma Society and met with a nutritionist. I changed my diet to reflect some of the recommendations based on those talks. I’m eating more of a plant-based diet and building up my strength as I approached treatment knowing that treatment was inevitable.
I saw a therapist weekly, which ultimately helped. During chemotherapy, I didn’t miss any work. I remained very active. I was still able to dance. I wasn’t allowed to skateboard anymore, but I was still exercising as much as I could to fight the fatigue and it paid off. That makes a big difference in terms of how one feels during the course of treatment and your ability to be resilient and make good progress in treatment.
Peter: I agree completely. It’s important to move. A lot of patients say that their treatment has debilitated them, but I tell them to try to move a couple of feet and take a couple of steps a day and build on it. It does make a difference.
Maximizing Your Quality of Life
Peter: Dr. Paludo, do you have any follow-up advice for Waldenström’s patients on how to deal with quality of life issues? Can they continue to live like they did before they had WM?
Dr. Paludo: Absolutely. It’s always difficult to cope with a new diagnosis of any cancer, including Waldenström’s. Every patient is a little different on how they try to cope. I try to understand what’s important for each patient and focus on what we can do to control what we can.
With Lisa, dancing was very important. We couldn’t control when treatment was needed, but we could control that she could continue to dance. It would be a form of exercise that helps her cope and keep some form of normalcy. Life can be disrupted with diagnosis and treatment, so trying to keep as much of a normal life as possible after diagnosis or when you’re going into treatment is very important. As you go through the watch and wait period with Waldenström’s before treatment or in between treatments, it’s very possible to live life like before as much as possible.
I’m not a mental health expert, so I also look for help. I refer my patients to cancer therapists and psychologists. The team we have at Mayo Clinic helps. I play within my limitations and always look for help from others who know more than I do about topics that are very important for every patient.
Patient Advocacy
Peter: Lisa, you’ve advocated for yourself right from the start. What would your advice be to newly-diagnosed patients or even those who are even in remission?
Lisa: For newly-diagnosed patients, get connected with IWMF. I was so impressed with the resources available for such a rare disease. It’s honestly very impressive how well IWMF is organized.
If you’re a young person or under 50, it can be more challenging because it’s almost a different disease. When you have young kids at home, there are a lot of different things to consider. Getting connected with the IWMF support group for young people was helpful. Find support with people in your community.
Watch lectures and read all the resources available sooner rather than later. You have some time to figure everything out. If you’re newly diagnosed and you don’t have symptoms that require immediate treatment, you have time to research.
It’s necessary, I would say also, to look at the different cancer institutes that have different philosophies. When you’re listening to lectures from different experts, find who resonates with you and what makes sense to you. Who do you seem to align with in terms of what feels right for you and what you value?
Take time to consider all that’s important to you so that you can locate the physician and your team that you’re hopefully going to be with for the rest of your life, working on achieving a good quality of life while living with this disease. Take in all the information, talk to your support network, and connect.
At first, I thought that having Dr. Paludo as my primary oncologist was not possible, but you may be surprised at what is possible so have hope and advocate for yourself.
It’s great to have an external brain to help process the information and to reflect back to you.
Lisa Ramirez
The Role of Care Partners
Peter: You approach each appointment with knowledge beforehand, you do your research, and you advocate for yourself. Do you go to your appointments on your own or do you take a care partner with you? You read that someone should always have someone else with them because they can mishear something. How do you manage that?
Lisa: I have a great partner and support. You’re absolutely right. Sometimes it can be overwhelming. When I would go to appointments with a different provider, I’d walk out sweating and notice I was so nervous during the appointment. Having someone there can be helpful. When I went to treatment, my partner would go with me. One time, my sister went with me.
Sometimes, you get disappointing news. I oddly got disappointed that I couldn’t do chemo a couple of times and I got upset and emotional, so to have someone to provide emotional support is helpful. It’s much better to not have to do it alone.
But if you are alone, there are people who are there to support you. At Mayo Clinic, there’s a whole team. Everybody there is supportive, so you can do it alone. It’s great to have an external brain to help process the information and to reflect back to you. Maybe you didn’t even notice that you weren’t feeling comfortable with a certain provider. It’s helpful to have someone to bounce off, so it’s important to have someone with you.
Peter: Dr. Paludo, what’s your advice in that regard? Do most patients come with someone to the appointment? And do you suggest it to patients if they don’t?
Dr. Paludo: Most patients come to their appointments with someone else. That’s very helpful and very important, if possible, of course. It’s difficult to take people away from their normal day-to-day lives, but it helps to have someone else also listening. We usually don’t remember everything that is discussed. Each person may remember different parts of the discussion. It helps, so I encourage that if possible.
Living with WM
Peter: Lisa, you’ve been living with Waldenström’s for a few years now. How do you not let Waldenström’s consume your everyday life? What’s your approach to living with it?
Lisa: In the beginning, it was difficult to not let it consume my life. For me, planning out a theoretical course of treatment to last my whole life was helpful. What helped was having that plan in place and also having a plan when I didn’t have symptoms or symptoms that I thought were bothersome to me.
Having those things mapped out in advance allows me to trust the plan and not have to think about it in my daily life. Once those decisions are made for the future, I can always change my mind at any point, but to have that mapped out for myself allows me to forget that I have Waldenström’s and live my life. It might take a minute to get there.
At first, it’s consuming. You’re consumed with the research. Don’t overreact. Take your time. Talk with your oncologist about a plan, put a plan in place, and then put it aside and live your life. Ultimately, treatment is all about having a good quality of life and living your life normally. You want to be able to do that and not add any additional stress to yourself. Putting a plan in place, putting it aside, and referring back to it when you need to is important.
Talk with your oncologist about a plan, put a plan in place, and then put it aside and live your life. Ultimately, treatment is all about having a good quality of life and living your life normally.
Lisa Ramirez
Waldenström: The Patient-Physician Relationship
Peter: Right from the start, you had a good relationship with Dr. Paludo. How has that evolved over the past few years? Is it different now than it was initially?
Lisa: Dr. Paludo has been very consistent. Initially, I met with him before I even met with who I thought was going to be my primary oncologist. I walked away from that conversation saying, “Gosh, I met the right oncologist for me. Too bad. I can’t possibly get treatment in Minnesota.”
It felt like a good fit from the beginning and we’ve built upon that trust. I instantly felt comfortable and felt trust. He engaged with me in a way that was strength-based and not over reactive. He’s very steady. Our relationship hasn’t changed much other than we’ve been through this treatment together and there’s a deepening of trust.
I’ve talked about my next treatment episode with my partner and when I have to do the weekly treatment, we’re going to live in Minnesota for six months. There’s no question about that. I know Dr. Paludo’s there for me and he’s my oncologist until the end, so I feel very comfortable with that.
Key Takeaways
Peter: Dr. Paludo, do you have any key takeaways for patients or healthcare providers in building and sustaining a strong relationship through the cancer journey?
Dr. Paludo: Advocate for yourself. Go after what you think is important for you. Lisa and I are on the same page. For the healthcare providers, what’s very important is to actively listen to each patient’s priorities. Listen and not just hear. Pay attention and focus on what’s important for each patient, like their main concerns and fears.
As providers, we have to be frank and honest with the limitations of what we know and what we don’t know about Waldenström’s. There are a lot of things that we know now that we didn’t know before, but there are a lot of questions that we can’t answer yet. Being honest with our limitations, paying attention, and focusing on what is important to the patient help build that trust, which is important in a relationship. We’re all going together through good and not-so-good moments in this long journey of Waldenström’s.
Being honest with our limitations, paying attention, and focusing on what is important to the patient help build that trust, which is important in a relationship.
Dr. Jonas Paludo
Peter: It’s good to see you’re both in agreement. You’re both following the proper path and I applaud both of you, especially for taking the time to share your experience with healthcare providers and patients.
Lisa mentioned that she first did a good bit of research through the IWMF website. I did that myself 20 years ago. I was a youngster back then and the services and support they provided meant so much to me that I started volunteering for the organization and I’ve been with them since then.
Waldenström’s is a rare disease, so you don’t encounter many people who have it, so finding an online community was of great benefit. Sharing stories with them, joining support groups, taking part in discussions, viewing webinars, and going to their annual educational forum are key components of becoming a more knowledgeable patient.
Before we had the technology, I would have my own chart that I would give to my doctor and say, “Here are my trends.” He would laugh at me, but he would look at it. We had a great relationship and that’s important to have. Be educated about your disease, know your options, what your preferred lifestyle, and what you want in quality of life, and pick a doctor who fits well.
Lisa: My therapist thinks Dr. Paludo is great.She’s convinced he took some classes in psychotherapy. She’s got great admiration for him. I’m also trained as a therapist and I would say Dr. Paludo has those skills, but please don’t leave the work you’re doing to be a therapist, although you’d be a great one.
Mayo Clinic is huge and yet after every visit, I would think, “How is it possible that each person on my care team was able to spend that much time with me?” I’ve never encountered that anywhere else. How is it that nurses remember me? People remember me. We had little inside jokes. Those things matter so much.
Our healthcare environment is changing. There’s limited time with patients. We’re speaking to healthcare institutions and I don’t know how providers get reimbursed and what expectations are in general.
Physicians want to have these kinds of relationships with their patients and perhaps there’s a larger pressure that prevents them from doing so. I hope that we can get back to that. Institutions like Mayo Clinic and physicians like Dr. Paludo give me the hope that it’s possible to have those kinds of relationships with patients in the current healthcare environment somehow.
Dr. Paludo: I don’t think I can say it better. It’s important to keep in mind what the priority is, which is the patient and what matters to that patient. Always keeping that in mind is the goal at the end of the day.
Conclusion
Peter: I enjoyed this discussion. It’s always good to meet with a fellow WMer and a noted, world-renowned Waldenström’s clinician and researcher. I’m very grateful for both of you for sharing your time. I hope others find this information very useful and beneficial as much as I did. Thank you both and thanks to The Patient Story.
Tiffany: Thank you, Pete, Lisa, and Dr. Paludo for an engaging discussion. It is so crucial to be empowered so that you and your caregivers can make informed decisions about your care.
Thanks again to our sponsor, Pharmacyclics, an AbbVie company, for its support of our independent patient program.
Thank you to Pharmacyclics, an AbbVie Company, for its support of our patient education program. The Patient Story retains full editorial control over all content.
Amber’s Stage 4B High-Grade Serous Ovarian Cancer Story
Interviewed by: Taylor Scheib Edited by: Katrina Villareal
Amber’s symptoms began subtly with bowel irregularities, night sweats, missed periods, unintended weight loss, fatigue, and pain, but she initially rationalized these as related to stress or her active lifestyle. With her mother battling stage 3 colorectal cancer at the time, she feared a similar diagnosis but delayed seeking medical help. By the fall of the same year, her symptoms had worsened significantly, including blood in her stool and severe discomfort, prompting her husband to schedule medical appointments.
After a colonoscopy revealed a mass, a subsequent emergency surgery determined Amber had stage 4 ovarian cancer, with the tumor spreading to both ovaries and her colon. This led to initial chemotherapy and the placement of an ileostomy bag. She later transferred care to a specialized center, where treatment included more chemotherapy to shrink the tumor before undergoing a radical hysterectomy and removal of other affected tissues. Genetic testing revealed she was BRCA1 positive, which shaped her treatment plan and ultimately led to the decision for a preventive double mastectomy two years after achieving remission.
Despite multiple allergic reactions to treatments and procedures, she persevered, completing six rounds of chemotherapy, a surgical recovery phase, and several years on a targeted PARP inhibitor. Though she mourned the loss of her fertility, she and her husband pursued fostering and adopted their daughter, who brought new purpose and joy to their lives. Now in remission, Amber reflects on the challenges of cancer, the trauma it caused, and the blessings that emerged through her resilience and determination.
Name: Amber C.
Diagnosis:
High-Grade Serous Ovarian Cancer
Staging:
Stage 4B
Symptoms:
Bowel irregularities (urgency, alternating constipation, and diarrhea)
Night sweats
Unintended weight loss
Irregular periods
Fatigue
Pain while sitting or going to the bathroom
Blood in stool
Treatments:
Surgeries: Debulking surgery, radical hysterectomy, oophorectomy, ileostomy placement, preventive double mastectomy with breast reconstruction
Chemotherapy
Targeted therapy: PARP inhibitor
This interview has been edited for clarity and length. This is not medical advice. Please consult with your healthcare provider to make informed treatment decisions.
The views and opinions expressed in this interview do not necessarily reflect those of The Patient Story.
